David S. Marks

2.8k total citations · 2 hit papers
23 papers, 1.8k citations indexed

About

David S. Marks is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David S. Marks has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David S. Marks's work include Coronary Interventions and Diagnostics (8 papers), Cardiac Imaging and Diagnostics (7 papers) and Cardiac Valve Diseases and Treatments (5 papers). David S. Marks is often cited by papers focused on Coronary Interventions and Diagnostics (8 papers), Cardiac Imaging and Diagnostics (7 papers) and Cardiac Valve Diseases and Treatments (5 papers). David S. Marks collaborates with scholars based in United States, Germany and United Kingdom. David S. Marks's co-authors include David E. Thaler, David Tirschwell, Jeffrey L. Saver, Lee MacDonald, Richard W. Smalling, John D. Carroll, Scott Berry, Katherine M. Detre, Michael Sandler and John F. LaDisa and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

David S. Marks

22 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke

2017 629 citations Jeffrey L. Saver, John D. Carroll et al. New England Journal of Medicine profile →
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke

2013 606 citations John D. Carroll, Jeffrey L. Saver et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Marks United States	15	1.3k	696	567	495	374	23	1.8k
Peter C. Spittell United States	14	1.1k 0.9×	936 1.3×	91 0.2×	186 0.4×	558 1.5×	33	1.7k
Motomi Ando Japan	25	2.1k 1.7×	1.4k 2.0×	85 0.1×	196 0.4×	572 1.5×	87	2.4k
Rolf Engberding Germany	14	836 0.7×	1.5k 2.2×	78 0.1×	327 0.7×	593 1.6×	31	2.0k
R. Don Patman United States	15	878 0.7×	422 0.6×	295 0.5×	193 0.4×	529 1.4×	23	1.2k
Mark E. O’Donnell United Kingdom	19	449 0.4×	213 0.3×	96 0.2×	169 0.3×	700 1.9×	82	1.3k
Francis J. Kazmier United States	22	1.3k 1.0×	774 1.1×	95 0.2×	148 0.3×	894 2.4×	37	2.0k
Ross T. Lyon United States	27	2.1k 1.7×	830 1.2×	191 0.3×	214 0.4×	1.2k 3.2×	59	2.4k
Metin Demircin Türkiye	16	494 0.4×	465 0.7×	66 0.1×	268 0.5×	561 1.5×	107	1.3k
Paul Calafiore Australia	19	532 0.4×	794 1.1×	64 0.1×	238 0.5×	264 0.7×	40	1.2k
Ahmed A. Khattab Switzerland	32	1.3k 1.1×	3.2k 4.6×	320 0.6×	1.1k 2.3×	1.6k 4.4×	100	4.2k

Countries citing papers authored by David S. Marks

Since Specialization

Citations

This map shows the geographic impact of David S. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Marks more than expected).

Fields of papers citing papers by David S. Marks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Marks. The network helps show where David S. Marks may publish in the future.

Co-authorship network of co-authors of David S. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Marks. A scholar is included among the top collaborators of David S. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Marks. David S. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCarthy, Robert J., Peter J. Mason, David S. Marks, & John F. LaDisa. (2025). Influence of boundary conditions and blood rheology on indices of wall shear stress from IVUS-based patient-specific stented coronary artery simulations. Scientific Reports. 15(1). 15868–15868. 1 indexed citations

LaDisa, John F., et al.. (2022). Advancements and Opportunities in Characterizing Patient-Specific Wall Shear Stress Imposed by Coronary Artery Stenting. Fluids. 7(10). 325–325. 8 indexed citations

Saver, Jeffrey L., John D. Carroll, David E. Thaler, et al.. (2017). Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. New England Journal of Medicine. 377(11). 1022–1032. 629 indexed citations breakdown →

Marks, David S., et al.. (2015). Benign Arterial Calcification on Screening Mammogram: A Marker for Coronary Artery Disease?. Journal of Women s Health. 24(10). 795–800. 16 indexed citations

Ellwein, Laura, et al.. (2015). Image‐based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design. Catheterization and Cardiovascular Interventions. 87(7). 1244–1255. 14 indexed citations

Carroll, John D., Jeffrey L. Saver, David E. Thaler, et al.. (2013). Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke. New England Journal of Medicine. 368(12). 1092–1100. 606 indexed citations breakdown →

Singh, Siddhartha, et al.. (2012). Impact of localizing general medical teams to a single nursing unit. Journal of Hospital Medicine. 7(7). 551–556. 28 indexed citations

Gundert, Timothy J., Alison L. Marsden, Weiguang Yang, David S. Marks, & John F. LaDisa. (2012). Identification of Hemodynamically Optimal Coronary Stent Designs Based on Vessel Caliber. IEEE Transactions on Biomedical Engineering. 59(7). 1992–2002. 30 indexed citations

Dieter, Robert S., et al.. (2006). Use of Gadolinium-Based Angiography for Renal Artery Stenting in a Patient With Renal Insufficiency. Angiology. 57(4). 526–529. 2 indexed citations

10.

Marks, David S., et al.. (2004). 1040-73 Financial impact of drug-eluting stents: The US academic experience. Journal of the American College of Cardiology. 43(5). A402–A402. 1 indexed citations

11.

Marks, David S., et al.. (2004). Mortality in Patients With Microvascular Disease. Journal of Clinical Hypertension. 6(6). 304–309. 46 indexed citations

12.

Mitrović, Veselin, Roland Willenbrock, Marija Miric, et al.. (2003). Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure. American Heart Journal. 145(3). E14–E14. 22 indexed citations

13.

Naidu, Srihari S., Faith Selzer, Alice K. Jacobs, et al.. (2003). Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. The American Journal of Cardiology. 92(10). 1160–1164. 97 indexed citations

14.

Naidu, Srihari S., Faith Selzer, Alice K. Jacobs, et al.. (2003). Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention: Current results from the NHLBI Dynamic Registry. Journal of the American College of Cardiology. 41(6). 1–1. 1 indexed citations

15.

Marks, David S., George A. Mensah, Elizabeth D. Kennard, Katherine M. Detre, & David R. Holmes. (2000). Race, baseline characteristics, and clinical outcomes after coronary intervention: The New Approaches in Coronary Interventions (NACI) registry. American Heart Journal. 140(1). 162–169. 24 indexed citations

16.

Robinson, V.J., et al.. (2000). Causes of Transient Dilatation of the Left Ventricle During Myocardial Perfusion Imaging. American Journal of Roentgenology. 174(5). 1349–1352. 23 indexed citations

17.

Burchenal, J.E.B., David S. Marks, J. Tift Mann, et al.. (1998). Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty. The American Journal of Cardiology. 82(4). 511–515. 26 indexed citations

18.

Marks, David S., et al.. (1983). Differentiation of focal intrahepatic lesions with 99mTc-red blood cell imaging.. Radiology. 146(3). 777–782. 37 indexed citations

19.

Sandler, Michael, et al.. (1980). Ultrasonic features and radionuclide correlation in liver cell adenoma and focal nodular hyperlasia.. Radiology. 135(2). 393–397. 28 indexed citations

20.

Khaja, Fareed, Md Jahangir Alam, Sidney Goldstein, Daniel T. Anbe, & David S. Marks. (1979). Diagnostic value of visualization of the right ventricle using thallium-201 myocardial imaging.. Circulation. 59(1). 182–188. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact